Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 6, 2006, Pages 2648-2654

  Schmitz Valckenberg, Steffen ^a   Bindewald Wittich, Almut ^a   Dolar Szczasny, Joanna ^b   Dreyhaupt, Jens ^c   Wolf, Sebastian ^d   Scholl, Hendrik P N ^a,e   Holz, Frank G ^a  

^a UNIVERSITY OF BONN   (Germany)

^b University of Lublin   (Poland)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHY; AUTOFLUORESCENCE; CLINICAL ARTICLE; CORRELATION COEFFICIENT; DATA BASE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; IMAGE QUALITY; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; STATISTICAL ANALYSIS; CLINICAL TRIAL; FLUORESCENCE; FLUORESCENCE ANGIOGRAPHY; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PIGMENT EPITHELIUM; PROGNOSIS; RETINA MACULA DEGENERATION;

LIPOFUSCIN;

AGED; AGED, 80 AND OVER; ATROPHY; DISEASE PROGRESSION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FLUORESCENCE; HUMANS; LIPOFUSCIN; LONGITUDINAL STUDIES; MACULAR DEGENERATION; MALE; MIDDLE AGED; PIGMENT EPITHELIUM OF EYE; PROGNOSIS;

EID: 33745641375     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0892     Document Type: Article

References (36)

1. Ferris FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102:1640-1642.
2. Sunness JS, Gonzales-Baron J, Applegate CA, et al. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. Ophthalmology. 1999;106:1768-1779.
3. Maguire P, Vine AK. Geographic atrophy of the retinal pigment epithelium. Am J Ophthalmol. 1986;102:621-625.
4. Holz FG, Wolfensberger TJ, Piguet B, et al. Bilateral drusen in age-related macular degeneration: prognosis and risk factors. Ophthalmology. 1994;101:1522-1528.
5. Schatz H, McDonald R. Atrophic macular degeneration. Rate of spread of geographic atrophy and visual loss. Ophthalmology. 1989;96:1541-1551.
6. Feeney-Burns L, Berman ER, Rothman H. Lipofuscin of human retinal pigment epithelium. Am J Ophthalmol. 1980;90:783-791.
7. Weiter JJ, Delori FC, Wing GL, Fitch KA. Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci. 1986;27:145-152.
8. Kennedy CJ, Rakoczy PE, Constable IJ. Lipofuscin of the retinal pigment epithelium: a review. Eye. 1995;9:763-771.
9. Sparrow JR, Boulton M. RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res. 2005;80:595-606.
10. Eldred GE, Lasky. Retinal age pigments generated by self-assembling lysosomotropic detergents. Nature. 1993;361:724-726.
11. Boulton M, McKechnie M, Breda J, Bayly M, Marshall J. The formation of auto-fluorescent granules in cultured human RPE. Invest Ophthalmol Vis Sci. 1989;30:82-89.
12. Holz FG, Schuett F, Kopitz J, et al. Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci. 1999;40:737-743.
13. Dorey KC, Wu G, Ebenstein D, Garsd A, Weiter JJ. Cell loss in aging retina: relationship to lipofuscin accumulation and macular degeneration. Invest Ophthalmol Vis Sci. 1989;30:1691-699.
14. Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci. 1995;36:718-729.
15. Rückmann AV, Fitzke FW, Bird AC. Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol. 1995;79:407-412.
16. Rückmann Av, Fitzke FW, Bird AC. Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci. 1997;38:478-486.
17. Bellmann C, Holz FG, Schapp O, Otto T, Völcker HE. Topographie der Fundusautofluoreszenz bestimmt mit einem konfokalen Scanning-Laser- Ophthalmoskop. Ophthalmologe. 1997;94:385-391.
18. Solbach U, Keilhauer C, Knabben H, Wolf S. Imaging of retinal autofluorescence in patients with age-related macular degeneration. Retina. 1997;17:385-389.
19. Holz FG, Bellmann C, Staudt S, Schütt F, Völcker HE. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2001;42:1051-1056.
20. Bindewald A, Schmitz-Valckenberg S, Jorzik JJ, et al. Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with AMD. Br J Ophthalmol. 2005;89:874-878.
21. Schmitz-Valckenberg S, Bültmann S, Dreyhaupt J, Bindewald A, Holz FG, Rohrschneider K. Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45:4470-4476.
22. Scholl HP, Bellmann C, Dandekar SS, Bird AC, Fitzke FW. Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy. Invest Ophthalmol Vis Sci. 2004;34:574-583.
23. Holz FG, Bellmann C, Rohrschneider K, Burk ROW, Völcker HE. Simultaneous confocal scanning laser fluorescein and indocyanine green angiography. Am J Ophthalmol. 1998;125:227-236.
24. Jorzik JJ, Bindewald A, Dithmar S, Holz FG. Digital simultaneous fluorescein and indocyanine green angiography, autofluorescence, and red-free imaging with a solid-state laser-based confocal scanning laser ophthalmoscope. Retina. 2005;25:405-416.
25. Bindewald A, Bird AC, Dandekar SS, et al. Classification of fundus autofluorescence patterns in early age-related macular disease. Invest Ophthalmol Vis Sci. 2005;46:3309-3314.
26. Lois N, Owens SL, Rosa C, et al. Fundus autofluorescence in patients with are-related macular degeneration and high risk of visual loss. Am J Ophthalmol. 2002;133:341-349.
27. Preparata FP, Hong SJ. Convex hulls of finite sets of points in two or three dimensions. Commun Assoc Comp Mach. 1977;20:87-93.
28. Hartung J. Statistik. Munich, Germany: Oldenbourg Verlag, 1989; 553-559.
29. The Eye Disease Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564-572.
30. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmology. 2003;48:257-293.
31. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419-421.
32. Edwards AO, Ritter R III, Kenneth JA, et al. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421-424.
33. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385-389.
34. Sarks SH. Drusen patterns predisposing to geographic atrophy of the retinal pigment epithelium. Aust J Ophthalmol. 1982;10:91-97.
35. Bergmann M, Schütt F, Holz F, Kopitz J. Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J. 2004;18:562-564.
36. Schütt F, Sallyanne D, Kopitz J, Holz FG. Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci. 2000;41:2303-2308.